Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 18;5(3):e002377.
doi: 10.1161/JAHA.115.002377.

Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study

José R Romero  1 , Sarah R Preis  2 , Alexa Beiser  3 , Charles DeCarli  4 , Ralph B D'Agostino  5 , Philip A Wolf  6 , Ramachandran S Vasan  7 , Joseph F Polak  8 , Sudha Seshadri  6
Affiliations

Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study

José R Romero et al. J Am Heart Assoc. .

Abstract

Background: Carotid atherosclerosis is associated with subclinical ischemic cerebrovascular disease, but its role in hemorrhage-prone small vessel disease-represented by cerebral microbleed (CMB)-is unclear, although vascular risk factors underlie both conditions. We hypothesized that persons with carotid atherosclerosis would have higher risk of CMB, particularly in deep regions.

Methods and results: We studied 1243 participants in the Framingham Offspring Study (aged 56.9±8.8 years; 53% women) with carotid ultrasound available on 2 occasions (1995-1998 and 2005-2008) prior to brain magnetic resonance imaging. Using multivariable logistic regression, we related baseline carotid stenosis, baseline intima-media thickness, and site-specific carotid intima-media thickness progression (at internal and common carotid locations) to the prevalence and location (lobar or deep plus mixed) of CMB. In addition, we assessed effect modification by lipid levels and use of statin and antithrombotic medications. Carotid stenosis ≥25% (a marker of cerebrovascular atherosclerosis) was associated with presence of CMB overall (Odds Ratio 2.20, 95% CI 1.10-4.40) and at deep and mixed locations (odds ratio 3.60, 95% CI 1.23-10.5). Baseline carotid intima-media thickness was not associated with CMB. Progression of common carotid artery intima-media thickness among persons on hypertension treatment was associated with lower risk of deep and mixed CMB (odds ratio per SD 0.41, 95% CI 0.18-0.96).

Conclusions: Cumulative vascular risk factor exposure may increase the risk of CMB, especially in deep regions. The apparent paradoxical association of carotid intima-media thickness progression with lower risk of CMB may reflect benefits of intensive vascular risk factor treatment among persons with higher cardiovascular risk and deserves further investigation. If replicated, the results may have potential implications for assessment of preventive and therapeutic interventions for subclinical cerebral hemorrhage.

Keywords: brain magnetic resonance imaging; carotid atherosclerosis; carotid intima–media thickness; cerebral microbleeds.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of selection of the study sample. CMB indicates cerebral microbleed; IMT, intima‐media thickness; MRI, magnetic resonance imaging.
See this image and copyright information in PMC

References

    1. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid‐artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14–22. - PubMed
    1. Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bonaa KH. Reduced neuropsychological test performance in asymptomatic carotid stenosis: the Tromso Study. Neurology. 2004;62:695–701. - PubMed
    1. Peters SA, den Ruijter HM, Bots ML. Attenuation of rate of change in carotid intima‐media thickness by lipid‐modifying drugs: impact on clinical outcomes. Am J Cardiovasc Drugs. 2011;11:253–263. - PubMed
    1. Ozaki K, Kubo T, Imaki R, Shinagawa H, Fukaya H, Ohtaki K, Ozaki S, Izumi T, Aizawa Y. The anti‐atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia. J Atheroscler Thromb. 2006;13:216–219. - PubMed
    1. Yu CM, Zhang Q, Lam L, Lin H, Kong SL, Chan W, Fung JW, Cheng KK, Chan IH, Lee SW, Sanderson JE, Lam CW. Comparison of intensive and low‐dose atorvastatin therapy in the reduction of carotid intimal‐medial thickness in patients with coronary heart disease. Heart. 2007;93:933–939. - PMC - PubMed

Publication types

MeSH terms